Levodopa

"Levodopa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.

Descriptor ID	D007980
MeSH Number(s)	D02.092.311.200.480 D12.125.072.050.685.400.500 D12.125.072.050.875.130.500
Concept/Terms	Levodopa Levodopa L-Dopa L Dopa 3-Hydroxy-L-tyrosine 3 Hydroxy L tyrosine L-3,4-Dihydroxyphenylalanine L 3,4 Dihydroxyphenylalanine Levopa Levopa Larodopa Larodopa Dopaflex Dopaflex Dopar Dopar

Below are MeSH descriptors whose meaning is more general than "Levodopa".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Amines [D02.092]
Catecholamines [D02.092.311]
Dihydroxyphenylalanine [D02.092.311.200]
Levodopa [D02.092.311.200.480]
Amino Acids, Peptides, and Proteins [D12]
Amino Acids [D12.125]
Amino Acids, Cyclic [D12.125.072]
Amino Acids, Aromatic [D12.125.072.050]
Phenylalanine [D12.125.072.050.685]
Dihydroxyphenylalanine [D12.125.072.050.685.400]
Levodopa [D12.125.072.050.685.400.500]
Tyrosine [D12.125.072.050.875]
Dihydroxyphenylalanine [D12.125.072.050.875.130]
Levodopa [D12.125.072.050.875.130.500]

Below are MeSH descriptors whose meaning is related to "Levodopa".

Below are MeSH descriptors whose meaning is more specific than "Levodopa".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Levodopa" by people in this website by year, and whether "Levodopa" was a major or minor topic of these publications.

Bar chart showing 20 publications over 16 distinct years, with a maximum of 2 publications in 2003 and 2008 and 2011 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	1	0	1
2002	1	0	1
2003	0	2	2
2007	1	0	1
2008	0	2	2
2010	0	1	1
2011	1	1	2
2013	1	0	1
2014	1	0	1
2015	0	1	1
2017	1	1	2
2018	1	0	1
2019	0	1	1
2020	1	0	1
2021	1	0	1
2025	1	0	1

Below are the most recent publications written about "Levodopa" by people in Profiles.

Camacho E, Dong Y, Chrissian C, Cordero RJB, Saraiva RG, Anglero-Rodriguez Y, Smith DFQ, Jacobs E, Hartshorn I, Pati?o-Medina JA, DePasquale M, Dziedzic A, Jedlicka A, Smith B, Mlambo G, Tripathi A, Broderick NA, Stark RE, Dimopoulos G, Casadevall A. Dietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in Anopheles mosquitos reducing their lifespan and malaria burden. Nat Commun. 2025 Aug 27; 16(1):8011.

View in: PubMed
Malave L, Zuelke DR, Uribe-Cano S, Starikov L, Rebholz H, Friedman E, Qin C, Li Q, Bezard E, Kottmann AH. Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson's disease and L-Dopa induced dyskinesia. Commun Biol. 2021 09 22; 4(1):1071.

View in: PubMed
Castello J, Cort?s M, Malave L, Kottmann A, Sibley DR, Friedman E, Rebholz H. The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia. Sci Rep. 2020 02 13; 10(1):2542.

View in: PubMed
Camacho E, Vij R, Chrissian C, Prados-Rosales R, Gil D, O'Meally RN, Cordero RJB, Cole RN, McCaffery JM, Stark RE, Casadevall A. The structural unit of melanin in the cell wall of the fungal pathogen Cryptococcus neoformans. J Biol Chem. 2019 07 05; 294(27):10471-10489.

View in: PubMed
Chatterjee S, Prados-Rosales R, Tan S, Phan VC, Chrissian C, Itin B, Wang H, Khajo A, Magliozzo RS, Casadevall A, Stark RE. The melanization road more traveled by: Precursor substrate effects on melanin synthesis in cell-free and fungal cell systems. J Biol Chem. 2018 12 28; 293(52):20157-20168.

View in: PubMed
Rajan R, Popa T, Quartarone A, Ghilardi MF, Kishore A. Cortical plasticity and levodopa-induced dyskinesias in Parkinson's disease: Connecting the dots in a multicomponent network. Clin Neurophysiol. 2017 06; 128(6):992-999.

View in: PubMed
Marinelli L, Quartarone A, Hallett M, Frazzitta G, Ghilardi MF. The many facets of motor learning and their relevance for Parkinson's disease. Clin Neurophysiol. 2017 07; 128(7):1127-1141.

View in: PubMed
Chatterjee S, Prados-Rosales R, Itin B, Casadevall A, Stark RE. Solid-state NMR Reveals the Carbon-based Molecular Architecture of Cryptococcus neoformans Fungal Eumelanins in the Cell Wall. J Biol Chem. 2015 May 29; 290(22):13779-90.

View in: PubMed
Smith ML, King J, Dent L, Mackey V, Muthian G, Griffin B, Charlton CG. Effects of acute and sub-chronic L-dopa therapy on striatal L-dopa methylation and dopamine oxidation in an MPTP mouse model of Parkinsons disease. Life Sci. 2014 Aug 06; 110(1):1-7.

View in: PubMed
Tse GG, Kim BB, McMurtray AM, Nakamoto BK. Case of levodopa toxicity from ingestion of Mucuna gigantea. Hawaii J Med Public Health. 2013 May; 72(5):157-60.

View in: PubMed

People

Explore

Similar Concepts

Top Journals